Continuing Education

Learning objectives

After participating in this activity, the learner should be better able to:

• Discuss how healthcare reform is affecting oncology care in the United States, including new payment systems
• Define comparative effectiveness and outline the issues surrounding its effect on cancer research and practice
• Summarize the scientific rationale and clinical evidence for using PARP inhibitors in patients with BRCA-deficient breast cancers
• Explain how to integrate new agents and treatment strategies into the clinical management of patients with melanoma
• Summarize clinical trial data on novel agents in the management of patients with NSCLC
• Examine advances in clinical and translational cancer research in breast, lung, prostate, melanoma, and colorectal cancers
• Identify the mechanisms of action, efficacy, safety, and indications for agents used to treat bone metastasis and cancer treatment-induced bone loss (CTIBL) including effects on tumor growth
• Outline the unique physiologic, social, and financial needs of the older patient with cancer
• Explain the most recent updates on the care of elderly patients with cancer
• Discuss the recent controversies surrounding the use of antiangiogenic agents in metastatic breast cancer
• Summarize recent updates on lymphoma and myeloma from the American Society of Hematology 2010 annual meeting
• Discuss the management of cardiovascular side effects of systemic treatments for cancer
• Outline treatment options for idiopathic thrombocytopenic purpura
• State treatment approaches for episodic pain in the cancer patient
• Identify issues and potential solutions that practice managers face in day-to-day business

Intended audience

This conference is designed for medical oncologists, hematologists, radiation oncologists, oncology nurses, administrators, and other oncology healthcare professionals.

CME/CNE accreditation

PHYSICIANS

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine and Global Academy for Medical Education. Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this educational activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSES

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by Global Academy for Medical Education.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 13.9

Participants desiring a CNE certificate must complete and hand in a Claim for Credit form (indicating sessions attended) and an Evaluation form.

Faculty disclosures

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.